Healthcare - Biotechnology - NASDAQ - US
$ 0.0002
0 %
$ 941
Market Cap
0.0
P/E
BALANCE SHEET
20.5 M
ASSETS
26.3 M
LIABILITIES
-5.8 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
eFFECTOR Therapeutics, Inc.
| Current Assets | 19.8 M |
| Cash & Short-Term Investments | 18.4 M |
| Receivables | 0 |
| Other Current Assets | 1.47 M |
| Non-Current Assets | 706 K |
| Long-Term Investments | 0 |
| PP&E | 193 K |
| Other Non-Current Assets | 513 K |
| Current Liabilities | 25.8 M |
| Accounts Payable | 2.33 M |
| Short-Term Debt | 20.5 M |
| Other Current Liabilities | 2.92 M |
| Non-Current Liabilities | 543 K |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 543 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 14.9 | 8.7 | 49.7 | 15.2 | 3.4 |
| Short Term Investments | 3.5 | 17.6 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 27 K | 100 K | 0 | 0 |
| Other Current Assets | 1.5 | 1.7 | 6.4 | 2.7 | 0.8 |
| Total Current Assets | 19.8 | 28.0 | 52.9 | 16.6 | 4.3 |
| PP&E | 0.2 | 0.4 | 0.3 | 0.1 | 0.8 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0.5 | 0.7 | 0.9 | (0.1) | (0.8) |
| Other Assets | 0 | 0 | 0 | 0 | 1 |
| Total Assets | 20.5 | 29.1 | 54.1 | 16.7 | 5.1 |
| LIABILITIES | |||||
| Accounts Payable | 2.3 | 1.5 | 0.5 | 0.3 | 0.6 |
| Short Term Debt | 20.5 | 20.2 | 88 K | 6.0 | 15.2 |
| Other Current Liabilities | 2.9 | 2.9 | 3.0 | 2.1 | 3.1 |
| Total Current Liabilities | 25.8 | 25.1 | 4.0 | 8.8 | 18.9 |
| Long Term Debt | 0 | 0.1 | 20.0 | 6.9 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.5 | 14 K | 12.8 | 133.2 | 0 |
| Total Liabilities | 26.3 | 25.2 | 36.8 | 148.9 | 18.9 |
| EQUITY | |||||
| Common Stock | 0 | 4 K | 4 K | 1 K | 1 K |
| Retained Earnings | (179.4) | (143.6) | (120.9) | (136.7) | (150.9) |
| Other Accumulative Comprehensive Income/Loss | 0 | 18 K | (54.1) | (133.2) | 999 |
| Total Equity | (5.8) | 3.9 | 17.3 | (132.2) | (13.8) |
| Total Liabilities and Equity | 20.5 | 29.1 | 54.1 | 16.7 | 5.1 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 2.2 | 1.6 | 1.6 | 0.6 | 0.6 |